Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Enzyme Stories

2013-05-24 08:23:09

TEMPE, Ariz., May 24, 2013 /PRNewswire/ -- The newly released flagship enzyme blend, Fibrenza(TM), utilizes advanced technology in a time-release capsule that offers the benefits of enteric coatings, without the use of synthetic chemicals. (Photo: http://photos.prnewswire.com/prnh/20130524/PH20296) Systemic enzyme use is at an all-time high, according to Heather Lewis, Brand Manager at HCP Formulas. She attributes much of the increased usage to social media. "Ten years ago, systemic...

2013-05-23 08:27:40

SAN DIEGO, May 23, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that Jeffrey Black, Chief Financial Officer, will present at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO) Mr. Black will present at the Second Annual Marcum LLP Microcap Conference on Thursday, May 30, 2013 at the Grand Hyatt Hotel in...

2013-05-21 16:23:12

TSXV: CST Outstanding shares: 79,687,836 QUEBEC CITY, May 21, 2013 /PRNewswire/ - CO(2) Solutions Inc. (TSXV: CST) is pleased to announce that it has renewed until March 31, 2015 its Joint Development Agreement (JDA) with Codexis, Inc. ("Codexis") to continue the development and deployment of CO(2) Solutions' enzymatic carbon capture technology. Under the amended and restated JDA, CO(2) Solutions' proprietary enzymatic method for the efficient capture of carbon...

2013-05-16 23:32:20

The novel Natural Sciences Bibliographic Web Portal aims to provide comprehensive bibliographic information on the basic and applied life, earth and health sciences and has published over 184,800 references and 133,600 tags. Scien.net has now newly included the category Polymerase which is an enzyme associated with polymers of nucleic acids such as the deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), and on Reductase, which is an enzyme that is known for catalyzing reduction and...

2013-05-15 08:24:07

Dyadic's C1 Technology Platform Enables BASF to Develop Enzymes for Multiple Market Segments LUDWIGSHAFEN, Germany and JUPITER, Fla., May 15, 2013 /PRNewswire/ -- BASF (BAS.DE) and Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI) announced today that the two Companies have entered into a non-exclusive worldwide research and license agreement. (Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO ) (Logo: http://photos.prnewswire.com/prnh/20130515/CL13970LOGO )...

2013-05-08 17:55:26

NREL research finds synergy in two approaches to breaking down cell walls of biomass Enzymes could break down cell walls faster — leading to less expensive biofuels for transportation — if two enzyme systems are brought together in an industrial setting, new research by the Energy Department´s National Renewable Energy Laboratory suggests. A paper on the breakthrough, “Fungal Cellulases and Complexed Cellulosomal Enzymes Exhibit Synergistic Mechanisms in Cellulose...

2013-05-07 08:24:43

JUPITER, Fla., May 7, 2013 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the industrial enzyme, bioenergy, and biopharmaceutical industries, announced today that Danai Brooks will join the Company as Executive Vice President and Chief Operating Officer in June. Brooks joins Dyadic from J.P. Morgan where he served as a Vice President in the...

2013-05-06 04:21:30

AMSTERDAM, May 6, 2013 /PRNewswire/ -- PharmaPendium Metabolizing Enzymes and Transporters Module delivers comprehensive visibility of Drug-Drug-Interactions Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical and medical information products and services, today announces that PharmaPendium [http://www.elsevier.com/pharmapendium ], the leading source of preclinical, clinical and post-market data, has added...

2013-05-02 08:37:50

SAN DIEGO, May 2, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will release first quarter 2013 financial results on Thursday, May 9, 2013 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Thursday, May 9, 2013 at 5:00 p.m. ET. (Logo:...

2013-04-25 08:27:26

TSX-V: CST Outstanding Shares: 79,687,836 QUEBEC CITY, April 25, 2013 /PRNewswire/ - CO(2) Solutions Inc. (TSX-V: CST), an innovator in the field of enzyme-enabled carbon capture technology, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application entitled Methods And Formulations Using Carbonic Anhydrase And Reaction Compound Combinations. "This patent will add to CO(2) Solutions' already robust U.S. patent...